LIVRQNac (AXA1125) ENHANCES INSULIN SENSITIVITY IN PRIMARY HUMAN HEPATOCYTES AND IN SUBJECTS WITH NAFLD AND T2D
Main Authors: | Seth J. Baum, Stephen A. Harrison, Nadege T. Gunn, Ziad H. Younes, Anita Kohli, Rashmee Patil, Juan P. Fras, Michael Hamill, Nadine Daou, Jeff Zhao, Manu V. Chakravarthy, Margaret J. Koziel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | American Journal of Preventive Cardiology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667721001185 |
Similar Items
-
Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
by: Finnigan, LEM, et al.
Published: (2023) -
Metabolic Changes of Hepatocytes in NAFLD
by: Qianrang Lu, et al.
Published: (2021-08-01) -
PENGKONTRUKSIAN SOLUSI EKSPLISIT PERSAMAAN MATRIKS X²AX=AXA
by: , IGNATIA SETIO P., et al.
Published: (2013) -
MENTALITY IN THE CULTURE OF THE LIAO EMPIRE (907 – 1125)
by: G. G. Pikov
Published: (2014-09-01) -
Remote access to Atomtex 1125A instrument
by: Urošević Vlade
Published: (2013-01-01)